Concepedia

Polly Clayden

PC

Statistics

Publications

28

Citations

2.2K

H-Index

21

Active since

2005

Affiliations

University College London(Current)

University of the Witwatersrand

University of Liverpool

Imperial College London

Columbia University

Polly Clayden is an author at University College London specializing in antiretroviral therapy, human immunodeficiency virus pharmacotherapy, and hiv prevention.

ORCID

Publications per year

2005–2024

28

Publications

28

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 717 citations · Full text

, , +17

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 260 citations · Full text

, , +17

Guidelines for the management of HIV infection in pregnant women and the prevention of mother‐to‐child transmission of HIV

David Hawkins, Maggie Blott, Polly Clayden et al. · HIV Medicine · 2005 · 153 citations

, , +16

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008

Annemiek de Ruiter, D Mercey, Jane Anderson et al. · HIV Medicine · 2008 · 145 citations · Full text

, , +17

British HIV Association guidelines for the management of<scp>HIV</scp>infection in pregnant women 2012

GP Taylor, Polly Clayden, Jyoti Dhar et al. · HIV Medicine · 2012 · 141 citations · Full text

, , +17

1–5 of 28